Interferon-γ: A key immunoregulatory lymphokine

Journal of Surgical Research

Volumn 54, Issue 1, 1993, Pages 79-93

  Williams, John G ^a   Jurkovich, Gregory J ^a   Maier, Ronald V ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; B LYMPHOCYTE ACTIVATION; DRUG MECHANISM; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INFLAMMATION; LEUKOCYTE ACTIVATION; MACROPHAGE ACTIVATION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; VASCULAR ENDOTHELIUM;

ENDOTHELIUM, VASCULAR; HUMAN; IMMUNITY; INTERFERON TYPE II; LYMPHOCYTES; MACROPHAGES; MONOCYTES; NEUTROPHILS; PROTEIN KINASE C; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027447381     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1006/jsre.1993.1013     Document Type: Review

References (153)

1. Isaacs, A., and Lindenmann, J. Virus interference. I. The interferon. Proc. R. Soc. Ser. B 147: 258, 1957.
2. Finter, N. B. The classification and biological functions of the interferons. J. Hepatol. 3: S157, 1986.
3. Strander, H., and Cantell, K. Production of interferon by human leukocytes in vitro. Ann. Med. Exp. Biol. Fenn. 44: 265, 1966.
4. Carlin, J. M., and Borden, E. C. Interferons and their induction. Immunol. Series 42: 3, 1988.
5. Billiau, A., and Dijkmans, R. Interferon-γ: Mechanism of action and therapeutic potential. Biochem. Pharm. 40: 1433, 1990.
6. Nathan, I., Groopman, J. E., Quan, S. G., Bersch, N., and Golde, D. W. Immune (γ) interferon produced by human T-lympho-blast cell line. Nature 292: 842, 1981.
7. Week, P. K., May, L., and Week, C. J. Gamma interferon production by different populations of human splenic lymphocytes. J. Interferon Res. 3: 121, 1983.
8. Epstein, L. B., Cline, M. J., and Merigan, T. C. The interaction of human macrophages and lymphocytes in the phytohemagglu-tinin-stimulated production of interferon. J. Clin. Invest. 50: 744.
9. Stanton, G. J., and Baron, S. Interferon and viral pathogenesis. In A. I. Notkins, and M. B. A. Oldstone (Eds.), Concepts in Viral Pathogenesis. New York: Springer-Verlag, 1985. P. 3.
10. Hannum, Y. A., and Bell, M. B. Mechanism of activation of protein kinase C: Role of diacylglycerol and calcium second messengers. Soc. Gen. Physiol. Ser. 42: 229, 1987.
11. Trinchieri, G., and Perussia, B. Immune interferon: A pleiotro-pic lymphokine with multiple effects. Immunol. Today 6: 131, 1985.
12. Braude, I. A. A simple and efficient method for the production of human gamma interferon. J. Immunol. Methods 63: 237, 1983.
13. Antonelli, G., Ruggiero, V., Cefaro, A., DiMarco, P., Amicucci, P., Colizzi, V., and Dianzani, F. Early steps in interferon-y production: Possible involvement of Ca-calmodulin-dependent enzymes. J. Interferon Res. 8: 193, 1988.
14. Mueller, G. C., and Wertz, P. W. A possible role of protein alkylation in phorbol ester action. Carcinog. Compr. Suru. 7: 499, 1982.
15. Levine, L., and Hassid, A. Effects of phorbol-12, 13-diesters on prostaglandin production and phospholipase activity in canine kidney (MDCK) cells. Biochem. Biophys. Res. Commun. 79: 477, 1977.
16. Serfling, E., Jasin, M., and Schaffner, W. Enhancers and eukaryotic gene transcription. Trends Genet. 1: 224, 1985.
17. Vervliet, G., Deckmyn, H., Carton, H., and Billiau, A. Influence of prostaglandin E2 and indomethacin on interferon gamma production by peripheral blood leukocytes of multiple sclerosis patients and healthy donors. J. Clin. Immunol. 5: 102, 1985.
18. Cesario, T. C., Yousefi, S., and Carandang, G. The regulation of interferon production by aspirin, other inhibitors of the cy-clooxygenase pathway and agents influencing calcium channel flux. Bull. N. Y. Acad. Med. 65: 26, 1989.
19. Johnson, H. M., Farrar, W. L., and Torres, B. A. Vasopressin replacement of interleukin 2 requirement in γ-interferon production, J. Immunol. 129: 2570, 1982.
20. Young, H. A., and Hardy, K. J. Interferon- γ: Producer cells, activation stimuli, and molecular genetic regulation. Pharmac. Ther. 45: 137, 1990.
21. Siggens, K. W., and Morris, A. G. Interferon-γ mRNA “superinduction” in human lymphocytes. Biochem. Biophys. Res. Commun. 133: 274, 1985.
22. Siggens, D., Tursley, J., and Morris, A. Role of protein synthesis in induction of IFN-γ by mitogens in human lymphocytes. Eur. J. Immunol. 15: 1079, 1985.
23. Naylor, S. L., Sakaguchi, A. Y., Shows, T. B., Lawn, M. L., Goeddel, D. V., and Gray, P. W. Human immune interferon gene is located on chromosome 12. J. Exp. Med. 57:1020, 1983.
24. Shows, T. B., Sakaguchi, A. Y., Naylor, S. L., Goeddel, D. V., and Lawn, R. M. Clustering of leukocyte and fibroblast interferon on human chromosome 9. Science 218: 373, 1982.
25. Vaquero, C., Sanceau, J., Sondermeyer, P., and Falcoff, R. Kinetics of messenger accumulation coding for IFN-γ, related to modifications in the poly(A) RNA population of activated human lymphocytes. Nucleic Acids Res. 12: 2629, 1984.
26. Kronke, M., Leonard, W. J., Depper, J. M., and Greene, W. C. Sequential expression of genes involved in human T lymphocyte growth and differentiation. J. Exp. Med. 161: 1593, 1985.
27. Shaw, J., Meerovitch, K., Elliott, J. F., Bleackley, R. C., and Paetkau, V. Induction, suppression and superinduction of lym-phokine mRNA in T lymphocytes. Mol. Immunol. 24: 409, 1987.
28. Revel, M., Bash, D., and Ruddle, F. H. Antibodies to a cell-sur-face component coded by human chromosome 21 inhibit action of interferon. Nature 260: 139, 1976.
29. Rashidbaigi, A., Langer, J. A., Jung, V., Jones, C., Morse, H. G., Tishfield, J. A., Trill, J. J., Kung, H., and Pestka, S. The gene for human immune interferon receptor is located on chromosome 6. Proc. Natl. Acad. Sci. USA 83: 384, 1986.
30. Rubinstein, M., Novick, D., and Fischer, D. G. The human interferon-γ receptor system. Immunol. Rev. 97: 29, 1987.
31. Anderson, P. Y., Yip, K., and Vilcek, J. Human interferon-gamma is internalized and degraded by cultured fibroblasts. J. Biol. Chem. 258: 6498, 1983.
32. Branca, A. A., Faltynek, C. R., D’Allessandro, S. B., and Bag-lioni, C. Interaction of interferon with cellular receptors, internalization and degradation of cell-bound interferon. J. Biol Chem. 257: 13291, 1982.
33. Bonnem, E. M., and Oldham, R. K. Gamma-interferon: Physiology and speculation on its role in medicine. J. Biol. Res. Mod. 6: 275, 1987.
34. Somers, S. D., Weiel, J. E., Hamilton, T. A., and Adams, D. O. Biochemical mechanisms of macrophage activation: Phorbol esters and calcium ionophore act synergistically to prime macrophages for tumor cell destruction. J. Immunol. 136: 4199, 1986.
35. Wright, B., Zeidman, I., Greig, R., and Poste, G. Inhibition of macrophage activation by calcium channel blockers and calmodulin antagonists. Cell. Immunol. 95: 46, 1985.
36. Adams, D. O., and Hamilton, T. A. Molecular transductional mechanisms by which IFN γ and other signals regulate macrophage development. Immunol Rev. 97: 5, 1987.
37. Hamilton, T. A., Somers, S. D., Becton, D. L., Celada, A., Schreiber, R. D. and Adams, D. O. Analysis of deficiencies in IFNy-mediated priming for tumor cytotoxicity in peritoneal macrophages from A/J mice. J. Immunol. 137: 3367, 1986.
38. Hamilton, T. A., Becton, D., Somers, S. D., Gray, P. A., and Adams, D. O. Interferon gamma modulates protein kinase C activity in murine peritoneal macrophages. J. Biol. Chem. 260: 1378, 1985.
39. Weiel, J. E., Hamilton, T. A., and Adams, D. O. LPS induces altered phosphate labeling of proteins in murine peritoneal macrophages. J. Immunol. 136: 3012, 1986.
40. Ijzermans, J., and Marquet, R. Interferon-gamma: A review. Immunobiology 179: 456, 1989.
41. Weil, J., Epstein, J., and Epstein, L. B. A unique set of polypeptides is induced by γ interferon in addition to those induced in common with α and β interferons. Nature 301: 437, 1983.
42. Tomita, Y. K., Cantell, K., and Kuwata, T, Effects of human gamma interferon on cell growth, replication of virus and induction of 2'5'-oligoadenylate synthetase in three human lympho-blastoid cell lines and K562 cells. Int. J. Cancer 30: 161, 1982.
43. Kronenberg, L. H., Rosenblatt, H. M., Bryson, Y., and Merigan, T. C. Interferon: Immunobiology and clinical significance. Ann. Int. Med. 96: 80, 1982.
44. Yu, S., Koerner, T., and Adams, D. Gene regulation in macrophage activation: Differential regulation of genes encoding for tumor necrosis factor, interleukin-1, JE, and KC by interferon-γ and lipopolysaccharide. J. Leuk. Biol. 48: 412, 1990.
45. Collart, M. A., Belin, D., Vassalli, J. D., and Vassalli, P. Modifications of functional activity in differentiated macrophages are accompanied by early and transient increase or decrease in c-fos gene transcription. J. Immunol. 139: 949, 1987.
46. Collart, M. A., Belin, D., Vassalli, J. D., DeKossodo, S., and Vassalli, P. γ-Interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors. J. Exp. Med. 164: 2113, 1986.
47. Peters, P. M., Svedersky, L. P., Shalaby, M. R., and Palladino, M. A., Jr. Interferon gamma: More than a MAF. Lymphokine Res. 4: 265, 1985.
48. Vilcek, J., Gray, E., Rinderknecht, E., and Sevastopoulos, C. G. Interferon-γ: A lymphokine for all seasons. Lymphokines 11:1, 1985.
49. Schultz, R. M., and Kleinschmidt, W. J. Functional identity between murine interferon and macrophage activating factor. Nature 305: 239, 1983.
50. Pace, J. L., Russell, S. W., Torres, B. A., Johnson, H. M., and Gray, P. W. Recombinant mouse γ interferon induces the priming step in macrophage activation for tumor cell killing. J. Immunol. 130: 2011, 1983.
51. Perussia, B., Dayton, E. T., Lazarus, R., Fanning, V., and Trin-chieri, G. Immune interferon induces the receptor for monomeric IgGl on human monocyte and myeloid cells. J. Exp. Med. 158: 1092, 1983.
52. Perussia, B., Dayton, E. T., Fanning, V., Thiagarajan, P., Howie, J., and Trinchieri, G. Immune interferon and leucocyte-conditioned medium induce normal and leukemic myeloid cells to differentiate along the monocytic pathway. J. Exp. Med. 158: 2058, 1983.
53. Ball, E. D., Guyre, P. M., Shen, L., Glynn, J. M., Maliszewski, C. R., Baker, P. E., and Fanger, M. W. Gamma interferon induces monocytic differentiation in the HL-60 cell line. J. Clin. Invest. 73: 1072, 1984.
54. Keller, R., Joller, P., Keist, R., Binz, H., and VanDerMeide, P. H. Modulation of major histocompatibility complex (MHC) expression by interferons and microbial agents. Scand. J. Immunol. 28: 113, 1988.
55. Basham, T. Y., and Merigan, T. C. Recombinant interferon-γ increases HLA-DR synthesis and expression. J. Immunol. 130: 1492, 1983.
56. Virelizier, J. L., and Arenzana-Seisdedos, F. Immunologic functions of macrophages and their regulation by interferons. Med. Biol. 63: 149, 1985.
57. Strassman, G., Springer, T. A., and Adams, D. O. Studies on antigens associated with the activation of murine mononuclear phagocytes: Kinetics of and requirements for induction of lymphocyte function-associated (LFA)-l antigen in vitro. J. Immunol. 135: 147, 1985.
58. Wong, G. W., Clark-Lewis, I., McKimm-Breschkin, J. L., Harris, A. W., and Schrader, J, W. Interferon-γ induces enhanced expression of la and H-2 antigens on B lymphoid, macrophage, and myeloid cell lines. J. Immunol. 131: 788, 1983.
59. Fridman, W. H., Gresser, I., Bander, M. T., Aguet, M., and Neauport-Sautes, C. Interferon enhances the expression of Fclg receptors. J. Immunol. 124: 2436, 1980.
60. Ball, E. D., Sorensen, G. D., and Pettengill, O. S. Expression of myeloid and histocompatibility antigens on small cell carcinoma of the lung cell lines analyzed by cytofluorography: Modulation by gamma interferon. Cancer Res. 46: 2335, 1986.
61. Odeyale, C. O., and Hook, G. R, Computer image analysis method for rapid quantitation of macrophage phagocytosis. J. Leukoc. Biol. 48: 403, 1990.
62. Degre, M., and Roll a g, H. Influence of interferon on the in vivo phagocytic activity of reticuJo endothelial system cells. J. Retie, Soc. 25: 489, 1979.
63. as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158: 670, 1983.
64. Paswell, J. H., Shor, R., and Shoham, J. The enhancing effect of interferon-β and -γ on the killing of Leishmania tropica major in human mononuclear phagocytes in vitro. J. Immunol. 136: 3062, 1986.
65. Lepay, D. A., Nathan, C. F., Murray, H. W., Steinman, R. M., and Cohn, Z. A. Murine Kupffer cells: Mononuclear phagocytes deficient in the generation of reactive oxygen intermediates. J. Exp. Med. 161: 1079, 1985.
66. Tyring, S. K., Klimpel, G., Brysk, M., Gupta, V., Stanton, G. J., Fleischmann, W. R. Jr., and Baron, S. Eradication of human melanoma cells by immune interferon and leucocytes. J. Natl. Cancer Inst. 73: 1067, 1984.
67. Chepekar, M. S., and Glazer, R. I. Effects of human immune interferon on cell viability, (2'5') oligoadenylate synthesis and polyamine dependent phosphorylation in human colon carcinoma cells in vitro. Cancer Res. 44: 2144, 1984.
68. Rubin, B. Y., Sekar, V., and Martimucci, W. A. Comparative antiproliferative efficacies of human alpha and gamma interferons. J. Gen. Viral. 64: 1753, 1983.
69. Katsushige, G., Makoto, M., and Nobuhiro, N. Characteristics of antiviral and anticellular activities of human recombinant interferon γ. GANN 76: 224, 1985.
70. Pfizenmaier, K., Bartsch, H., Scheurich, P., Seliger, B., Ucer, U., Vehmever, K. and Nagel, G. A. Differential gamma-inter-feron response of human colon carcinoma cells: Inhibition of proliferation and modulation of immunogenicity as independent effects of gamma-interferon on tumor cell growth. Cancer Res. 45: 3503, 1985.
71. Lee, S. H., Aggarwal, B. B., Rinderknecht, E., Assisi, F., and Chiu, H. The synergistic ant-proliferative effect of gamma-in-terferon and human lymphotoxin. J. Immunol. 133: 1083, 1984.
72. Arenzana-Siesdedos, F., and Virelizier, J. L. Interferons as macrophage-activating factors. II. Enhanced secretion of interleukin 1 by lipopolysaccharide-stimulated human monocytes. Eur. J. Immunol. 13: 437, 1983.
73. Nedwin, G. E., Svedersky, L. P., Bringman, T. S., Palladino, M. A., and Goeddel, D. V. Effect of interleukin-2, interferon-gamma and mitogens on the production of tumor necrosis factors alpha and beta. J. Immunol 4: 2492, 1985.
74. Williams, J. G., Jurkovich, G. J., Hahnel, G. B., and Maier, R. V. Macrophage priming by interferon gamma: A selective process. J. Leukocyte Biol., in press.
75. Sanders, K. M., and Littman, B. H. Lymphokine stimulation of macrophage C2 production is partially due to interferon-gamma. J. Immunol. 137: 876, 1986.
76. Strunk, R. C., Cole, F. S., Perlmutter, D. H., and Colten, H. R. γ-Interferon increases expression of class III complement genes C2 and factor B in human monocytes and in murine fibroblasts transfected with human C2 and factor B genes. J. Biol. Ckem. 260: 15280, 1985.
77. Lotz, M., and Zuraw, B. L. Interferon-γ is a major regulator of Cl-inhibitor synthesis by human blood monocytes. J. Immunol. 139: 3382, 1987.
78. Ruddy, S., Gigli, I., and Austen, K. F. The complement system of man. N. Eng. J. Med. 287: 489, 1972.
79. Hogg, T. C. Neutrophil kinetics and lung injury. Physiol. Rep. 67: 1249, 1987.
80. Tate, R., and Repine, J. Neutrophils and the adult respiratory distress syndrome. Am. Rev. Resp. Dis. 128: 552, 1983.
81. Oldham, K., Guice, K., Till, G., and Ward, P. Activation of complement by hydroxyl radicals in thermal injury. Surgery 104: 272, 1988.
82. Fernandez, H. N., Henson, P. M., Otani, A., and Hugli, T. E. Chemotactic response to human C3a and C5a anaphylatoxins. 1. Evaluations of C3a and C5a leukotaxis in vitro and under simulated in vivo conditions. J. Immunol. 120: 109, 1978.
83. Frank, M. M, Complement in the pathophysiology of human disease. N. Engl. J. Med. 316: 1525, 1987.
84. Ross, G. D. Analysis of the different types of leukocyte complement receptors and their interactions with the complement system. J. Immunol. Methods 37: 197, 1980.
85. Schopf, E., Hammann, K. P., Scheiner, O., Lemmel, E. M., and Dierich, M. P. Activation of human monocytes by both human 1H and C3b. Immunology 46: 307, 1982.
86. Schreiber, R. D., Pangburn, M. K., Bjornson, A. B., Brothers, M. A., and Muller-Eberhard, H. J. The role of C3 fragments in endocytosis and extracellular cytotoxic reactions by polymorphonuclear leukocytes. Clin. Immunol. Immunopathol. 23: 335, 1982.
87. Goldstein, I. M. Complement: Biologically active products. In J. I. Gallin, I. M. Goldstein, and R. Synderman (Eds.), Inflammation: Basic Principles and Clinical Correlates. New York: Raven Press, 1988. Pp. 55-74.
88. Tonnesen, M. G., Smedley, L. A., and Henson, P. M. Neutrophil-endothelial cell interactions. Modulation of neutrophil adhesiveness induced by complement fragments C5a and C5a des arg and formyl-methionyl-leucyl-phenyl-alanine in vitro. J. Clin. Invest. 74: 1581, 1984.
89. Volk, W. A. In C. May (Ed.), Essentials of Medical Microbiology. Philadelphia: Lippincott, 1978. Pp. 249-250.
90. Sonnefeld, G., Mandel, A. D., and Merigan, T. C. Time and dosage dependence of immuno-enhancement by murine type II interferon preparations. Cell Immunol. 40: 285, 1978.
91. Brunswick, M., and Lake, P. Obligatory role of gamma interferon in T cell replacing factor-dependent, antigen specific murine B cell response. J. Exp. Med. 161: 953, 1985.
92. Leibson, H. J., Gefter, M., Zlotnik, A., Marrack, P., and Kappler, J. W. Role of gamma-interferon in antibody producing responses. Nature 309: 799, 1984.
93. Sidman, C. L., Marshall, J. D., Shultz, L. D., Gray, P. W., and Johnson, H. M. Gamma-interferon is one of several direct B cell-maturing lymphokines. Nature 309: 801, 1984.
94. Mond, J. J., Finkelman, F. D., Sarma, C., OHara, J., and Serrate, S. Recombinant interferon-gamma inhibits B cell proliferative response stimulated by soluble but not by Sepharose-bound anti-immunoglobulin antibody. J. Immunol. 135: 2513, 1985.
95. Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., and Coffman, R. L. Two types of murine helper cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136: 2348, 1986.
96. Reynolds, D. S., Boom, W. H., and Abbas, A. K. Inhibition of B lymphocyte activation by interferon-gamma. J. Immunol. 139: 767, 1987.
97. Snapper, C. M., and Paul, W. E. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236: 944, 1987.
98. Adolf, G. R. Structure and effects of interferon-gamma. Oncology 42: 33, 1985.
99. Herberman, R. B. Interferon and cytotoxic effector cells. In Vil-cek and DeMaeyer (Eds.), Interferons and the immune system. Amsterdam: Elsevier, 1984. Pp. 61-84.
100. Raulet, D. H., and Bevan, J. J, A differentiation factor required for the expression of cytotoxic T cell function. Nature 296; 754, 1982.
101. Takai, Y., Herrmann, S. H., Greenstein, J. L., Spitalny, G. L., and Burakoff, S. J. Requirement for three distinct lymphokines for the induction of cytotoxic lymphocytes from thymocytes. J. Immunol. 137: 3494, 1986.
102. Thornhill, M. H. and Haskard, D. O. IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-gamma. J. Immunol. 145: 865, 1990.
103. Thornhill, M. H., Wellicome, S. M., Mahiouz, D. L., Lanch-bury, J. S., Kyan-Aung, U., and Haskard, D. O. Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms. J. Immunol. 146: 592, 1991.
104. Thornhill, M. H., Kyan-Aung, U., Lee, T. H., and Haskard, D. O. T cells and neutrophils exhibit differential adhesion to cytokine-stimulated endothelial cells. Immunology 69: 287, 1990.
105. Steinbeck, M. J., Roth, J. A., and Kaeberle, M. L. Activation of bovine neutrophils by recombinant interferon-gamma. Cell. Immunol. 98: 137, 1984.
106. Bielefeldt, O. H., and Babiuk, L. A. Alteration of some leukocyte functions following in vivo and in vitro exposure to recombinant bovine alpha and gamma interferon. J. Interferon Res. 6: 123, 1986.
107. Petroni, K. C., Shen, L., and Guyre, P. M, Modulation of human polymorphonuclear leukocyte IgG Fc receptors and Fc receptor-mediated functions by IFN-gamma and glucocorticoids. J. Immunol. 140: 3467, 1988.
108. Perussia, B., Kobayashi, M., Rossi, M. E., Anegon, I., and Trin-chieri, G. Immune interferon enhances functional properties of human granulocytes: Role of Fc receptors and effect of lympho-toxin, tumor necrosis factor, and granulocyte-macrophage colony-stimulating factor. J. Immunol. 138: 765, 1987.
109. Livingston, D. H., Appel, S. H., Sonnenfeld, G., and Malangoni, M. A. The effect of tumor necrosis factor-alpha and interferon-gamma on neutrophil function. J. Surg. Res. 46: 322, 1989.
110. Shen, L., Guyre, P. M., and Fanger, M. W. Polymorphonuclear leukocyte function triggered through the high affinity Fc receptor for monomeric IgG. J. Immunol. 139: 534.
111. Fu, Y. K., Arkins, S., Wang, B. S., and Kelley, K, W. A novel role of growth hormone and insulin-like growth factor-I. Priming neutrophils for superoxide anion secretion. J. Immunol. 146: 1602, 1991.
112. Suzuki, K., Furui, H., Kaneko, M., Takagi, K., and Satake, T. Priming effect of recombinant human interleukin-2 and recombinant human interferon-gamma on human neutrophil super-oxide production. Arzneimittelforschung 40: 1176, 1990.
113. Berton, G., Zeni, L., Cassatella, M. A., and Rossi, F. Gamma interferon is able to enhance the oxidative metabolism of human neutrophils. Biochem. Biophy. Res. Commun. 138: 1276, 1986.
114. Morrison, C. J., and Stevens, D. A. Enhanced killing of Blastomyces dermatitidis by gamma interferon-activated murine peripheral blood polymorphonuclear neutrophils. Int. J. Immuno-pharmacol. 11: 855, 1989.
115. Djeu, J. Y., Blanchard, D. K., Halkias, D., and Friedman, H. Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: Activation by interferon-gamma and tumor necrosis factor. J. Immunol. 137: 2980, 1986.
116. Cotran, R. S., and Pober, J. S. Endothelial activation. Its role in inflammatory and immune reactions. In N, Simionescu and M. Simionescu (Eds.), Endothelial Cell Biology. New York: Plenum, 1988, Pp. 335.
117. Demling, R. H. Current concepts on the adult respiratory distress syndrome. Circ. Shock 30: 297, 1990.
118. Cotran, R. S. New roles for the endothelium in inflammation and immunity. Am. J. Path. 129: 407, 1987.
119. Gray, P. W., Leung, D. W., Pennica, D., Yelverton, E., Najar-ian, R., Simonsen, C. C., Derynck, R., Sherwood, R. T., Wallace, D. M., Berger, S. L., Levinson, A. D., and Goeddel, D. Expression of human immune interferon cDNA in E. coli and monkey cells. Nature 295: 503, 1982.
120. Rinderknecht, T., O’Connor, B. H., and Rodrigues, H. Natural human interferon-gamma: Complete amino acid sequence and determination of sites of glycosylation, J. Biol. Chem. 259: 6797, 1984.
121. Rinderknecht, T., O’Connor, B. H., and Rodrigues, H. Investigators brochure: A multicenter trial of recombinant human interferon-gamma in serious trauma victims at risk for infection. Genentech, Inc. South San Francisco, 1988.
122. Sherwin, S. A., Foon, K. A., Abrams, P. G., Heyman, M. R., Ochs, J. J., Maluish, A. E., and Oldham, R. K. A preliminary phase I trial of partially purified interferon-gamma in patients with cancer. J. Biol. Resp. Modifiers 3: 599, 1984.
123. Gutterman, J. U., Rosenblum, M. G., Rios, A. A., Fritche, H., and Quesada, J. Continuous intravenous infusion of partially purified gamma interferon in cancer patients. Cancer Res. 44: 4164, 1984.
124. Foon, K. A., Sherwin, S. A., Abrams, P. G., Stevenson, H. C., Holmes, P., Maluish, A. E., Oldham, R. K., and Herberman, R. B. A phase I trial of recombinant gamma interferon in patients with cancer. Cancer Immunol. Immunother. 20: 193, 1985.
125. Kurzrock, R., Rosenblum, M. G., Sherwin, S. A., Rios, A., Tal-paz, M., Quesada, J. R., and Gutterman, J. U. Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-interferon in cancer patients. Cancer Res. 45: 2866, 1985.
126. Vadhan-Raj, S., Al-Katib, A., Bhalla, R., Pelus, P., Nathan, C. F., Sherwin, J. A., Oettgen, H. F., and Krown, S. E. Phase I trial of recombinant interferon gamma in cancer patients. J. Clin. Oncol. 4: 137, 1986.
127. Jaffe, H. S., and Sherwin, S. A. The early clinical trials of recombinant human interferon-gamma. In R, Freedman, T., Merigan, T., Sreevalson (Eds.), Interferons as Cell Growth Inhibitors and Antitumor Factors. New York: A. R. Liss, 1986.
128. Quesada, J. R., Kurzrock, R., Sherwin, S. A., and Gutterman, J. U. Phase II studies of recombinant human interferon gamma in metastatic renal cell carcinoma. J. Biol. Resp. Mod. 6: 20, 1987.
129. Kurzrock, R., Talpaz, M., Kantarjian, H., Walters, R., Saks, S., Trujillo, J. M., and Gutterman, J. U. Therapy of chronic myelogenous leukemia with recombinant interferon-gamma. Blood 70: 943, 1987.
130. Jaffe, H. S., Chen, A. B., Kramer, S., and Sherwin, S. A. The absence of interferon antibody formation in patients receiving recombinant human interferon-gamma. J. Biol. Resp. Mod. 6: 576, 1987.
131. Adams, D. O., and Hamilton, T. A. The cell biology of macrophage activation. Ann. Rev. Immunol. 2: 283, 1984.
132. Murray, W. Interferon-gamma, the activated macrophage, and host defense against microbial challenge. Ann. Int. Med. 108: 595, 1988.
133. Wirth, J., Kierszenbaum, F., Sonnenfeld, G., and Zlotnik, A. Enhancing effects of gamma interferon on phagocytic cell asso-elation and killing of Trypanosoma cruzi. Infect. Immun. 49: 61, 1985.
134. Kleinerman, E. S., Kurzrock, R., Wyatt, D., Quesada, J. R., Gutterman, J. U., and Fidler, I. J. Activation or suppression of the tumoricidal properties of monocytes from cancer patients following treatment with human recombinant gamma-inter-feron. Cancer Res. 46: 5401, 1986.
135. Nathan, C. F., Horowitz, C. R., DeLa Harpe, J., Vadhan-Raj, S., Sherwin, S. A., Oettgen, H. F., and Krown, S. E. Administration of recombinant interferon gamma to cancer patients enhances monocyte secretion of hydrogen peroxide. Proc. Natl. Acad. Sei. USA 82: 868, 1985.
136. Kirby, P., Wells, D., Kiviat, N., and Corey, L. A phase I trial of intramuscular human gamma interferon for refractory genial warts. Clin. Res. 34: 759A, 1986.
137. Badaro, R., Falcoff, E., Badaro, F. S., Carvalho, E. M., et al. Treatment of visceral leishmaniasis with pentavalent antimony and interferon-gamma. N. Engl J. Med. 322: 16, 1990.
138. Nathan, C. R., Kaplan, G., Levis, W. R., Nusraf, A., Witmer, M. D., Sherwin, S. A., Job, C. K., Horowitz, C. R., Steinman, R. M., and Cohn, Z. A. Local and systemic effects of low doses of recombinant interferon-gamma after intradermal injection in patients with lepromatous leprosy. N. Engl. J. Med. 315: 6, 1986.
139. Gallin, J. I., Malech, H. L., Weening, R. S., Curnutte, J. T., Quie, P. G., Jaffe, H. S., and Ezekowitz, R. A. B. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N. Engl. J. Med. 324: 509, 1991.
140. Faist, E., Mewes, A., Strasser, T., Walz, A., Alkan, S., Baker, C., Ertel, W., and Heb er er, G. Alteration of monocyte function following major injury. Arch. Surg. 123: 287, 1988.
141. Lehner, T., and Jones, T. The role of MND class II antigenic determinants in the function of human antigen binding t8+ cells, monocytes and helper and suppressor factors. Clin. Exp. Immunol. 56: 683, 1984.
142. Unanue, E. R., Beller, D. I., Lu, C. Y., and Allen, P. M. Antigen presentation: comments on its regulation and mechanism. J. Immunol. 132: 1, 1984.
143. Polk, H. C., Wellhausen, S. R., Regan, M. P., Cost, K., Davidson, P. R., Regan, M. P., and Borzotta, A. P. A systematic study of host defense processes in badly injured patients. Ann. Surg. 204: 282, 1986.
144. Livingston, D., Appel, S., Wellhausen, S., Sonnenfeld, G., and Polk, H. Depressed interferon gamma production and monocyte HLA-DR expression after severe injury. Arch. Surg. 123: 1309, 1988.
145. Hershman, M. J., Appel, S. H., Wellhausen, S. R., Sonnenfeld, G., and Polk, H. C. Interferon-gamma increases HLA-DR expression on monocytes in severly injured patients. J. Interferon Res. 7: 695, 1987.
146. Maluish, A. E., Urba, W. J., Longo, D. L., Overton, W. R., Cog-gin, D., Crisp, E. R., Williams, R., Sherwin, S. A., Gordon, K., and Steis, R. G. The determination of an immunologically active dose of interferon-gamma in patients with melanoma. J. Clin. Oncol. 6: 434, 1988.
147. Livingston, D. H., and Malangoni, M. A. Interferon-gamma restores immune competence after hemorrhagic shock. J. Surg. Res. 45: 37, 1988.
148. Jurkovich, G. J., Mileski, W. J., Maier, R. V., Winn, R. K., and Rice, C. L. Interferon-gamma increases sensitivity to endotoxin. J. Surg. Res. 51: 197, 1991.
149. Pober, J. S., Gimbrone, M. J., Lapierre, L., Mendrick, D., Fiers, W., Rothlein, R., and Springer, T. Overlapping patterns of activation of human endothelial cells by interleukin-1, tumor necrosis factor, and immune interferon. J. Immunol. 137: 1893, 1986.
150. Bevilacqua, M., Brock, A., Arnout, M., and Gimbrone, M. Endo-tbelial-leukocyte adhesion: Contributions of endothelia-depen-dent and leukocyte-dependent mechanisms. FASEB J. 2:1603, 1988.
151. DeMaeyer-Guinyaad, J., and DeMaeyer, E. Immunomodula-tion by interferons: Recent developments. Interferon 6: 69, 1985.
152. Mogensen, S., and Vrelizer, J. The interferon-macrophage alliance. Interferon 8: 55, 1987.
153. Ruggiero, V., Tavernier, J., Fiers, W., and Baglioni, C. Induction of the synthesis of tumor necrosis factor receptors by interferon-gamma. J. Immunol. 136: 2445, 1986.